Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2007 1
2008 1
2009 1
2010 2
2011 5
2012 7
2013 5
2014 2
2015 2
2016 8
2017 9
2018 9
2019 7
2020 10
2021 18
2022 6
2023 5
2024 7
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis.
Gooptu M, Romee R, St Martin A, Arora M, Al Malki M, Antin JH, Bredeson CN, Brunstein CG, Chhabra S, Fuchs EJ, Ghosh N, Grunwald MR, Kanakry CG, Kekre N, McGuirk JP, McNiece IK, Mehta RS, Mielcarek M, Milano F, Modi D, Reshef R, Solomon SR, Schroeder MA, Waller EK, Inamoto Y, Soiffer RJ, Eapen M. Gooptu M, et al. Among authors: milano f. Blood. 2021 Jul 22;138(3):273-282. doi: 10.1182/blood.2021011281. Blood. 2021. PMID: 34292325 Free PMC article.
Posttransplant cyclophosphamide (PTCy) graft-versus-host disease (GVHD) prophylaxis has enabled haploidentical (Haplo) transplantation to be performed with results similar to those after matched unrelated donor (MUD) transplantation with traditional prophylaxis. ... …
Posttransplant cyclophosphamide (PTCy) graft-versus-host disease (GVHD) prophylaxis has enabled haploidentical (Haplo) transplantation …
Mutant NPM1 Maintains the Leukemic State through HOX Expression.
Brunetti L, Gundry MC, Sorcini D, Guzman AG, Huang YH, Ramabadran R, Gionfriddo I, Mezzasoma F, Milano F, Nabet B, Buckley DL, Kornblau SM, Lin CY, Sportoletti P, Martelli MP, Falini B, Goodell MA. Brunetti L, et al. Among authors: milano f. Cancer Cell. 2018 Sep 10;34(3):499-512.e9. doi: 10.1016/j.ccell.2018.08.005. Cancer Cell. 2018. PMID: 30205049 Free PMC article.
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial.
Cowan AJ, Pont MJ, Sather BD, Turtle CJ, Till BG, Libby EN 3rd, Coffey DG, Tuazon SA, Wood B, Gooley T, Wu VQ, Voutsinas J, Song X, Shadman M, Gauthier J, Chapuis AG, Milano F, Maloney DG, Riddell SR, Green DJ. Cowan AJ, et al. Among authors: milano f. Lancet Oncol. 2023 Jul;24(7):811-822. doi: 10.1016/S1470-2045(23)00246-2. Lancet Oncol. 2023. PMID: 37414012 Free PMC article. Clinical Trial.
We included individuals aged 21 years or older with relapsed or refractory multiple myeloma, previous autologous stem-cell transplant or persistent disease after more than four cycles of induction therapy, and Eastern Cooperative Oncology Group performance status of 0-2, r …
We included individuals aged 21 years or older with relapsed or refractory multiple myeloma, previous autologous stem-cell transplant …
Guidelines for Cord Blood Unit Selection.
Politikos I, Davis E, Nhaissi M, Wagner JE, Brunstein CG, Cohen S, Shpall EJ, Milano F, Scaradavou A, Barker JN; American Society for Transplantation and Cellular Therapy Cord Blood Special Interest Group. Politikos I, et al. Among authors: milano f. Biol Blood Marrow Transplant. 2020 Dec;26(12):2190-2196. doi: 10.1016/j.bbmt.2020.07.030. Epub 2020 Jul 28. Biol Blood Marrow Transplant. 2020. PMID: 32736011 Free article. Review.
Optimal cord blood (CB) unit selection is critical to maximize the likelihood of successful engraftment and survival after CB transplantation (CBT). However, unit selection can be complex because multiple characteristics must be considered including unit cell dose, donor-r …
Optimal cord blood (CB) unit selection is critical to maximize the likelihood of successful engraftment and survival after CB transplanta …
Cord blood transplantation: rewind to fast forward.
Dahlberg A, Milano F. Dahlberg A, et al. Among authors: milano f. Bone Marrow Transplant. 2017 Jun;52(6):799-802. doi: 10.1038/bmt.2016.336. Epub 2016 Dec 19. Bone Marrow Transplant. 2017. PMID: 27991893 Review.
The utilization of cord blood as a source of stem cells for transplantation has decreased in recent years. Although cord blood transplantation (CBT) is an established practice for the treatment of adult and pediatric patients with hematological malignancies, the hig …
The utilization of cord blood as a source of stem cells for transplantation has decreased in recent years. Although cord blood tra …
Reply to Author.
Hill JA, Pergam SA, Boeckh M, Milano F. Hill JA, et al. Among authors: milano f. Biol Blood Marrow Transplant. 2018 Oct;24(10):2166. doi: 10.1016/j.bbmt.2018.06.030. Epub 2018 Jun 30. Biol Blood Marrow Transplant. 2018. PMID: 29969748 Free PMC article. No abstract available.
Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.
Barker JN, Kurtzberg J, Ballen K, Boo M, Brunstein C, Cutler C, Horwitz M, Milano F, Olson A, Spellman S, Wagner JE, Delaney C, Shpall E. Barker JN, et al. Among authors: milano f. Biol Blood Marrow Transplant. 2017 Jun;23(6):882-896. doi: 10.1016/j.bbmt.2017.03.006. Epub 2017 Mar 6. Biol Blood Marrow Transplant. 2017. PMID: 28279825 Free PMC article. Review.
Unrelated donor cord blood transplantation (CBT) results in disease-free survival comparable to that of unrelated adult donor transplantation in patients with hematologic malignancies. ...Targeted care strategies in CBT recipients can mitigate early transplantati …
Unrelated donor cord blood transplantation (CBT) results in disease-free survival comparable to that of unrelated adult donor tran …
Measurable residual disease as predictor of post-day +100 relapses after allografting in adult AML.
Ali N, Othus M, Rodríguez-Arbolí E, Orvain C, Milano F, Sandmaier BM, Davis C, Basom RS, Appelbaum FR, Walter RB. Ali N, et al. Among authors: milano f. Blood Adv. 2025 Feb 11;9(3):558-570. doi: 10.1182/bloodadvances.2024013214. Blood Adv. 2025. PMID: 39374582 Free PMC article.
Measurable residual disease (MRD) by multiparametric flow cytometry (MFC) before allogeneic hematopoietic cell transplantation (HCT) identifies patients at high risk of acute myeloid leukemia (AML) relapse, often occurring early after allografting. To examine the role of M …
Measurable residual disease (MRD) by multiparametric flow cytometry (MFC) before allogeneic hematopoietic cell transplantation (HCT) …
Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML.
Orvain C, Ali N, Othus M, Rodríguez-Arbolí E, Milano F, Le CM, Sandmaier BM, Scott BL, Appelbaum FR, Walter RB. Orvain C, et al. Among authors: milano f. Am J Hematol. 2024 May;99(5):862-870. doi: 10.1002/ajh.27259. Epub 2024 Feb 21. Am J Hematol. 2024. PMID: 38380817
Multiparameter flow cytometry (MFC) measurable residual disease (MRD) before allogeneic hematopoietic cell transplantation (HCT) independently predicts poor outcomes in acute myeloid leukemia (AML). ...
Multiparameter flow cytometry (MFC) measurable residual disease (MRD) before allogeneic hematopoietic cell transplantation (HCT) inde …
Guidelines for Adult Patient Selection and Conditioning Regimens in Cord Blood Transplant Recipients with Hematologic Malignancies and Aplastic Anemia.
Metheny L, Politikos I, Ballen KK, Rezvani AR, Milano F, Barker JN, Brunstein CG; American Society for Transplantation and Cellular Therapy Cord Blood Special Interest Group. Metheny L, et al. Among authors: milano f. Transplant Cell Ther. 2021 Apr;27(4):286-291. doi: 10.1016/j.jtct.2020.11.008. Transplant Cell Ther. 2021. PMID: 33836867 Free article. Review.
For cord blood transplantation (CBT), appropriate patient and conditioning regimen selection is necessary to achieve long-term disease-free survival. ...
For cord blood transplantation (CBT), appropriate patient and conditioning regimen selection is necessary to achieve long-term diseas …
93 results